RVRC Revium Rx.
Price Chart
Executive Summary
Revium Rx. announced the resignation of CFO Arie Gordashnikov effective May 27, 2026, with no reported disagreement. The Board simultaneously appointed Igor Bluvstein as CFO, effective immediately. Bluvstein brings CFO experience at Argent BioPharma and G Medical Innovations. The change appears orderly with a replacement in place.
Actionable Insight
This is a routine CFO transition with an experienced replacement. Monitor for any strategic or financial changes in subsequent filings, but no immediate trading action warranted.
Key Facts
- CFO Arie Gordashnikov resigned effective May 27, 2026
- Resignation not due to any disagreement with the company
- Igor Bluvstein appointed as CFO effective same day
- Bluvstein previously served as CFO at Argent BioPharma Ltd. (ASX: RGT) and G Medical Innovations Holdings Ltd. (NASDAQ: GMVD)
- New CFO's compensation: monthly retainer of NIS17,000 plus VAT
Financial Impact
No material financial impact; CFO compensation is routine and immaterial
Risk Factors
- Potential short-term disruption from CFO transition
- New CFO's familiarity with Revium's operations and industry-specific challenges unknown
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-063235 |
| Document: 0001213900-26-063235-index-headers.html | 0001213900-26-063235 |
| Document: 0001213900-26-063235-index.html | 0001213900-26-063235 |
| Document: 0001213900-26-063235.txt | 0001213900-26-063235 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
4d ago
|
8-K
| $1.67 $1.67 | · 0.00% | ▼ −0.14% | $1.67 (−0.00%) |
|
Apr 20, 2026
6w ago
|
8-K
| $1.67 $1.67 | · 0.00% | ▼ −1.02% | $1.67 (−0.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access